Volume 7; Issue supp-S2

European Neuropsychopharmacology

Volume 7; Issue supp-S2
4

S.01.03 Neurosteroids and the peripheral benzodiazepine receptor

Year:
1997
Language:
english
File:
PDF, 282 KB
english, 1997
7

S.02.04 The effects of clomethiazole in animal models of stroke

Year:
1997
Language:
english
File:
PDF, 146 KB
english, 1997
8

S.03.01 Advantages and disadvantages of lithium augmentation

Year:
1997
Language:
english
File:
PDF, 146 KB
english, 1997
11

S.03.05 Prioritizing augmentation strategies in resistant depression

Year:
1997
Language:
english
File:
PDF, 288 KB
english, 1997
12

S.04.02 Epidemiology of social phobia

Year:
1997
Language:
english
File:
PDF, 293 KB
english, 1997
13

S.04.03 Implications of early onset social phobia on outcome

Year:
1997
Language:
english
File:
PDF, 147 KB
english, 1997
14

S.04.04 Biological basis for social phobia

Year:
1997
Language:
english
File:
PDF, 283 KB
english, 1997
15

S.04.05 The pharmacological treatment of social phobia

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
16

S.05.01 Overview of CRF in psychiatric diseases

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
20

S.05.05 Future perspectives in CRH research

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
21

S.06.01 Does early treatment have an effect on outcome?

Year:
1997
Language:
english
File:
PDF, 285 KB
english, 1997
22

S.06.04 Choice of drug to improve cognitive function

Year:
1997
Language:
english
File:
PDF, 148 KB
english, 1997
23

S.06.05 Guidelines for investigating drugs in schizophrenia

Year:
1997
Language:
english
File:
PDF, 293 KB
english, 1997
24

S.07.01 Impact of chronobiology for treatment of affective disorders

Year:
1997
Language:
english
File:
PDF, 148 KB
english, 1997
26

S.07.03 Serotonergic side effects

Year:
1997
Language:
english
File:
PDF, 151 KB
english, 1997
27

S.07.04 Electroconvulsive therapy: Acute treatment and long term perspective

Year:
1997
Language:
english
File:
PDF, 298 KB
english, 1997
34

S.10.01 Animal models of relapse

Year:
1997
Language:
english
File:
PDF, 304 KB
english, 1997
35

S.10.02 Endorphins and relapse; basic studies

Year:
1997
Language:
english
File:
PDF, 308 KB
english, 1997
36

S.10.03 Psychological strategies for relapse prevention in alcoholism

Year:
1997
Language:
english
File:
PDF, 153 KB
english, 1997
37

S.10.04 Pharmacotherapy of relapse prevention in alcoholism

Year:
1997
Language:
english
File:
PDF, 301 KB
english, 1997
39

S.11.02 Are rapid onset and superior outcome related?

Year:
1997
Language:
english
File:
PDF, 308 KB
english, 1997
40

S.11.03 Potential rapid onset: Mechanisms of action

Year:
1997
Language:
english
File:
PDF, 304 KB
english, 1997
41

S.11.04 Can we identify subgroups for targeted adjunctive treatment?

Year:
1997
Language:
english
File:
PDF, 147 KB
english, 1997
42

S.12.01 Predictors of response

Year:
1997
Language:
english
File:
PDF, 291 KB
english, 1997
43

S.12.02 Differences among anti-obsessive medications

Year:
1997
Language:
english
File:
PDF, 147 KB
english, 1997
44

S.12.03 How long is long enough in treatment of obsessive compulsive disorders?

Year:
1997
Language:
english
File:
PDF, 147 KB
english, 1997
48

S.13.04 Galanin receptors and their functional characterization

Year:
1997
Language:
english
File:
PDF, 289 KB
english, 1997
50

S.14.01 Predictors of response to neuroleptic treatment in schizophrenia

Year:
1997
Language:
english
File:
PDF, 299 KB
english, 1997
52

S.14.05 Treatment resistence: Are there specific strategies?

Year:
1997
Language:
english
File:
PDF, 145 KB
english, 1997
53

S.15.01 Stress, depression and hormones

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
54

S.15.02 Gonadal steroids, brain, and behavior

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
55

S.15.03 Serotonin reuptake inhibitors in the treatment of premenstrual dysphoria

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
58

S.17.01 Regulation of transcription factors by signal transduction pathways

Year:
1997
Language:
english
File:
PDF, 151 KB
english, 1997
60

S.17.03 Antipsychotic drugs and neurotransmitter receptor regulation

Year:
1997
Language:
english
File:
PDF, 303 KB
english, 1997
63

S.18.01 Schizophrenia — Pharmacoeconomic consequences of negative symptoms

Year:
1997
Language:
english
File:
PDF, 143 KB
english, 1997
66

S.18.04 Evidence of efficacy of neuroleptics in effective versus negative symptoms

Year:
1997
Language:
english
File:
PDF, 294 KB
english, 1997
67

S.18.05 Non neuroleptic treatments for negative symptoms

Year:
1997
Language:
english
File:
PDF, 137 KB
english, 1997
68

S.19.02 Biological basis for treatment of anorexia nervosa

Year:
1997
Language:
english
File:
PDF, 288 KB
english, 1997
69

S.19.03 Is there a specific psychopharmacology for eating disorders?

Year:
1997
Language:
english
File:
PDF, 301 KB
english, 1997
70

S.19.04 Pharmacological maintenance strategies for bulimia nervosa

Year:
1997
Language:
english
File:
PDF, 149 KB
english, 1997
71

S.20.01 Comparison of treatment outcome in children and in adults with OCD

Year:
1997
Language:
english
File:
PDF, 304 KB
english, 1997
75

S.21.03 Dopamine D4 receptor antagonists, schizophrenia and beyond?

Year:
1997
Language:
english
File:
PDF, 300 KB
english, 1997
76

S.21.04 Pharmacological characterization of dopamine D3 and D4 receptor ligands

Year:
1997
Language:
english
File:
PDF, 301 KB
english, 1997
77

S.21.05 Clinical importance of D3/D4 receptor antagonists

Year:
1997
Language:
english
File:
PDF, 148 KB
english, 1997
78

S.22.01 How should we treat mania?

Year:
1997
Language:
english
File:
PDF, 297 KB
english, 1997
79

S.22.02 Long-term prophylactic treatment priorities in bipolar disorder

Year:
1997
Language:
english
File:
PDF, 291 KB
english, 1997
80

S.22.04 Rapidly cycling bipolar disorder: Overview of the concept and empirical findings

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
81

S.22.05 Implications of comorbidity for treatment in bipolar disorder

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
82

S.23.03 SSRIs and other new treatments in panic disorder

Year:
1997
Language:
english
File:
PDF, 286 KB
english, 1997
83

S.23.04 Long-term treatment of panic disorder-agoraphobia

Year:
1997
Language:
english
File:
PDF, 148 KB
english, 1997
85

S.25.03 Neuroendocrine assessment of 5-HT1a receptors

Year:
1997
Language:
english
File:
PDF, 302 KB
english, 1997
87

S.25.05 The 5-HT2C receptor-potential therapeutic opportunities

Year:
1997
Language:
english
File:
PDF, 147 KB
english, 1997
89

S.26.03 A PET-study of extrastriatal D2-dopamine receptors

Year:
1997
Language:
english
File:
PDF, 301 KB
english, 1997
90

S.26.04 EEG/ERP-mapping as a tool in psychopharmacology

Year:
1997
Language:
english
File:
PDF, 155 KB
english, 1997
92

S.27.01 Psychopharmacology of impulsivity and aggression in childhood and adolescence

Year:
1997
Language:
english
File:
PDF, 253 KB
english, 1997
93

S.27.04 Clozapine metabolism in early onset schizophrenia

Year:
1997
Language:
english
File:
PDF, 142 KB
english, 1997
94

S.28.01 Exelon™ in alzheimer's disease

Year:
1997
Language:
english
File:
PDF, 142 KB
english, 1997
95

S.28.04 Muscarinic agonists in the treatment of alzheimer's disease

Year:
1997
Language:
english
File:
PDF, 297 KB
english, 1997
96

S.28.05 The role of antidepressants in the treatment of dementia

Year:
1997
Language:
english
File:
PDF, 198 KB
english, 1997
98

P.1.002 The use and tolerability of venlafaxine in old depressed patients

Year:
1997
Language:
english
File:
PDF, 124 KB
english, 1997
101

P.1.005 Trazodone and priapism

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
104

P.1.008 The role of paroxetine in the treatment of anxiety disorders

Year:
1997
Language:
english
File:
PDF, 139 KB
english, 1997
122

P.1.026 An open study with sertraline in outpatients with dysthymia

Year:
1997
Language:
english
File:
PDF, 144 KB
english, 1997
127

P.1.031 The role of clonidine in the treatment of manic episodes

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
132

P.1.037 The use of drugs in depression the last decade

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
138

P.1.043 Dual (NA + 5-HT) versus single (5-HT) acting antidepressants, clinical overview

Year:
1997
Language:
english
File:
PDF, 146 KB
english, 1997
140

P.1.045 Mechanisms of action of antidepressants

Year:
1997
Language:
english
File:
PDF, 142 KB
english, 1997
143

P.1.048 Effects of first-trimester fluoxetine exposure on the newborn

Year:
1997
Language:
english
File:
PDF, 145 KB
english, 1997
144

P.1.049 Treatment resistant depression — A biochemical hypothesis

Year:
1997
Language:
english
File:
PDF, 145 KB
english, 1997
145

P.1.050 Refractory depression (A new model for definition)

Year:
1997
Language:
english
File:
PDF, 282 KB
english, 1997
162

P.1.067 Use and understanding of antidepressant medications in primary care

Year:
1997
Language:
english
File:
PDF, 136 KB
english, 1997
166

P.1.071 Tolerability of mirtazapine used in high or low initial dose

Year:
1997
Language:
english
File:
PDF, 286 KB
english, 1997
167

P.1.072 Lack of pharmacokinetic interactions between mirtazapine and lithium

Year:
1997
Language:
english
File:
PDF, 142 KB
english, 1997
170

P.1.075 Citalopram in depressed cardiac patients

Year:
1997
Language:
english
File:
PDF, 280 KB
english, 1997
171

P.1.076 Bipolar I disorder and affective temperament

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
176

P.1.081 Agitated depression in elderly-safety treatment with moclobemide

Year:
1997
Language:
english
File:
PDF, 280 KB
english, 1997
182

P.1.087 Immunotropic effect of nootrop in patients with major depression

Year:
1997
Language:
english
File:
PDF, 143 KB
english, 1997
183

P.1.088 Pharmacotheraphy of depressive disorders in period of involution

Year:
1997
Language:
english
File:
PDF, 291 KB
english, 1997
184

P.1.089 Pharmacotherapy of pre-menstrual syndrome

Year:
1997
Language:
english
File:
PDF, 152 KB
english, 1997
190

P.1.095 Clinical pharmacological profile of the RIMA RS-8359

Year:
1997
Language:
english
File:
PDF, 146 KB
english, 1997
192

P.1.097 The clinical relevance of the cytochrome P450 enzyme system to antidepressants

Year:
1997
Language:
english
File:
PDF, 291 KB
english, 1997
193

P.1.098 Early phase II results of the RIMA RS-8359

Year:
1997
Language:
english
File:
PDF, 149 KB
english, 1997
204

P.1.109 Fluoxetine in inpatients. A naturalistic study

Year:
1997
Language:
english
File:
PDF, 142 KB
english, 1997
217

P.1.122 Tolerability of mirtazapine in a naturalistic patient setting

Year:
1997
Language:
english
File:
PDF, 271 KB
english, 1997
223

P.1.128 Mobility patterns in bipolar affective disorder

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
224

P.1.129 Mirtazapine in old age depression

Year:
1997
Language:
english
File:
PDF, 278 KB
english, 1997
226

P.1.131 Duration of hospitalisation and its modelings

Year:
1997
Language:
english
File:
PDF, 144 KB
english, 1997
231

P.1.136 Melatonin add-on in manic patients with treatment resistant insomnia

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
233

P.1.138 Depression in breast cancer patients — comparison of paroxetine and amitriptyline

Year:
1997
Language:
english
File:
PDF, 262 KB
english, 1997
236

P.1.141 Humoral phototransduction.: Is albumine involved?

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
242

P.1.147 Pharmacotherapy of depression in elderly patients: The role of sertraline

Year:
1997
Language:
english
File:
PDF, 283 KB
english, 1997
243

P.1.148 The safety of fluoxetine during pregnancy

Year:
1997
Language:
english
File:
PDF, 147 KB
english, 1997
245

P.1.151 Efficacy and tolerability of paroxetine in the long-term management of panic

Year:
1997
Language:
english
File:
PDF, 147 KB
english, 1997
248

P.1.154 Acupuncture possibilities in depressive patients treatment

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
256

P.1.162 Mirtazapine in recurrent brief depression (RBD)

Year:
1997
Language:
english
File:
PDF, 282 KB
english, 1997
265

P.1.171 Magnesium in mild depressive disorders

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
274

P.1.180 Which impact has comorbidity in therapy resistant depression?

Year:
1997
Language:
english
File:
PDF, 134 KB
english, 1997
282

P.2.002 Drug abuse in schizophrenia

Year:
1997
Language:
english
File:
PDF, 133 KB
english, 1997
286

P.2.006 Neuroleptic response in chronic schizophrenia and movement disorders

Year:
1997
Language:
english
File:
PDF, 131 KB
english, 1997
306

P.2.026 Suicide attempts in schizophrenia

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
308

P.2.028 Sleep deprivation in schizophrenic patients with negative symptoms

Year:
1997
Language:
english
File:
PDF, 142 KB
english, 1997
311

P.2.031 Selection bias in clinical trials with antipsychotics

Year:
1997
Language:
english
File:
PDF, 143 KB
english, 1997
315

P.2.035 The efficacy of zotepine in reducing BPRS total score

Year:
1997
Language:
english
File:
PDF, 127 KB
english, 1997
319

P.2.039 Pharmacoepidemiology of antipsychotic

Year:
1997
Language:
english
File:
PDF, 131 KB
english, 1997
320

P.2.040 National survey on patients with antipsychotic

Year:
1997
Language:
english
File:
PDF, 131 KB
english, 1997
321

P.2.041 Risperidone in the treatment of acute schizophrenic episodes

Year:
1997
Language:
english
File:
PDF, 131 KB
english, 1997
322

P.2.042 The long term cardiovascular safety of sertindole

Year:
1997
Language:
english
File:
PDF, 124 KB
english, 1997
323

P.2.043 The action of sertindole on negative symptoms in schizophrenia

Year:
1997
Language:
english
File:
PDF, 124 KB
english, 1997
328

P.2.048 Clozapine and suicide: A case report

Year:
1997
Language:
english
File:
PDF, 268 KB
english, 1997
330

P.2.050 Pseudoneurotic form of schizophrenia

Year:
1997
Language:
english
File:
PDF, 132 KB
english, 1997
331

P.2.051 Weight gain induced by clozapine

Year:
1997
Language:
english
File:
PDF, 132 KB
english, 1997
332

P.2.052 A ten year follow-up of tardive dyskinesia in a nursing home population

Year:
1997
Language:
english
File:
PDF, 255 KB
english, 1997
333

P.2.053 Effects of risperidone and other antipsychotic agents on sleep quality

Year:
1997
Language:
english
File:
PDF, 126 KB
english, 1997
334

P.2.054 The use of risperidone for young patients: Clinical experience

Year:
1997
Language:
english
File:
PDF, 126 KB
english, 1997
339

P.2.059 New perspectives in the treatment of schizophrenic patients

Year:
1997
Language:
english
File:
PDF, 287 KB
english, 1997
343

P.2.063 The efficacy of zotepine in reducing negative symptoms

Year:
1997
Language:
english
File:
PDF, 123 KB
english, 1997
351

P.2.071 The tolerability and efficacy of intramuscular ziprasidone

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
353

P.2.074 Hyperthermia as an occasional therapy

Year:
1997
Language:
english
File:
PDF, 136 KB
english, 1997
356

P.2.077 Tolerability and cardiovascular safety of risperidone

Year:
1997
Language:
english
File:
PDF, 135 KB
english, 1997
357

P.2.078 Clotiapine: Another forgotten treasure in psychiatry?

Year:
1997
Language:
english
File:
PDF, 135 KB
english, 1997
362

P.2.083 Sertindole in clinical practice

Year:
1997
Language:
english
File:
PDF, 148 KB
english, 1997
370

P.2.091 Metabolism of zotepine by man and animals

Year:
1997
Language:
english
File:
PDF, 145 KB
english, 1997
382

P.2.103 Subjective response to new antipsychotics

Year:
1997
Language:
english
File:
PDF, 139 KB
english, 1997
384

P.2.105 Zotepine in the treatment of chronic schizophrenia

Year:
1997
Language:
english
File:
PDF, 139 KB
english, 1997
385

P.2.106 A comparison of zotepine and chlorpromazine on BPRS subscores

Year:
1997
Language:
english
File:
PDF, 263 KB
english, 1997
386

P.2.107 Clinical questions about clozapine

Year:
1997
Language:
english
File:
PDF, 127 KB
english, 1997
387

P.2.108 Prediction of acute treatment efficacy in schizophrenic disorder

Year:
1997
Language:
english
File:
PDF, 127 KB
english, 1997
394

P.2.117 The clinical actions of risperidone

Year:
1997
Language:
english
File:
PDF, 137 KB
english, 1997
395

P.3.001 Paroxetine in panic disorder

Year:
1997
Language:
english
File:
PDF, 137 KB
english, 1997
396

P.3.002 Sertraline vs clomipramine in obsessive-compulsive disorder

Year:
1997
Language:
english
File:
PDF, 265 KB
english, 1997
397

P.3.003 Salivary cortisol in panic disorder

Year:
1997
Language:
english
File:
PDF, 130 KB
english, 1997
400

P.3.006 Panic disorder and agoraphobia: An aetiological model

Year:
1997
Language:
english
File:
PDF, 265 KB
english, 1997
402

P.3.008 Dizziness, panic attacks and agoraphobia

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
405

P.3.012 Use of sedative hypnotics in elderly psychiatric patients

Year:
1997
Language:
english
File:
PDF, 144 KB
english, 1997
407

P.3.014 Clinical subtypes of panic attacks in panic disorder

Year:
1997
Language:
english
File:
PDF, 277 KB
english, 1997
411

P.3.018 The prevalence of social phobia in Hungary

Year:
1997
Language:
english
File:
PDF, 269 KB
english, 1997
414

P.3.021 The therapy of war-traumatized adolescents

Year:
1997
Language:
english
File:
PDF, 135 KB
english, 1997
416

P.3.023 Social phobia: A follow up study

Year:
1997
Language:
english
File:
PDF, 271 KB
english, 1997
420

P.3.027 Epidemiology of OCD in Hungary

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
422

P.3.029 Interaction between ondansetron and oxazepam in tolerant rats

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
438

P.3.045 “Pure” OCD— does it exist? Study of comorbidity in OCD

Year:
1997
Language:
english
File:
PDF, 131 KB
english, 1997
439

P.3.046 Anterograde amnesia in suicide attempters who took benzodiazepines

Year:
1997
Language:
english
File:
PDF, 131 KB
english, 1997
445

P.3.052 Panic disorders treatment with psychotherapy and pharmacotherapy combined method

Year:
1997
Language:
english
File:
PDF, 125 KB
english, 1997
452

P.3.062 Meta-analysis of sertraline in panic disorder

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
453

P.3.063 Sertraline 50 mg/day as a treatment for panic disorder

Year:
1997
Language:
english
File:
PDF, 282 KB
english, 1997
458

P.4.004 Pharmacological treatment of alzheimer's disease

Year:
1997
Language:
english
File:
PDF, 145 KB
english, 1997
461

P.4.007 Angiotensin II receptors: New targets for neuroprotection

Year:
1997
Language:
english
File:
PDF, 146 KB
english, 1997
465

P.4.011 Mild cognitive disorders in elderly GP-patients

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
471

P.4.017 Calbindin D-28K and NADPH-diaphorase in the cortex in alzheimer's disease

Year:
1997
Language:
english
File:
PDF, 139 KB
english, 1997
479

P.4.026 Ticlid in the treatment of atherosclerotic encephalopathy

Year:
1997
Language:
english
File:
PDF, 137 KB
english, 1997
481

P.5.002 Bipolar disorders treatment with sodium valproate

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
483

P.5.005 Predictors of outcome in a naltrexone maintenance treatment

Year:
1997
Language:
english
File:
PDF, 108 KB
english, 1997
484

P.5.006 Paroxetine vs amitryptiline in depressed alcoholics

Year:
1997
Language:
english
File:
PDF, 108 KB
english, 1997
488

P.5.010 Dependence and negative symptoms

Year:
1997
Language:
english
File:
PDF, 134 KB
english, 1997
490

P.5.012 Fluoxetine in severe alcohol dependence

Year:
1997
Language:
english
File:
PDF, 145 KB
english, 1997
497

P.5.019 Pharmacotherapy of alcoholic patients

Year:
1997
Language:
english
File:
PDF, 130 KB
english, 1997
498

P.5.020 Nalmefene modification of alcoholism

Year:
1997
Language:
english
File:
PDF, 130 KB
english, 1997
501

P.5.023 Use of benzodiazepines by drug addicts

Year:
1997
Language:
english
File:
PDF, 142 KB
english, 1997
502

P.5.024 Treatment of depressed alcoholics

Year:
1997
Language:
english
File:
PDF, 142 KB
english, 1997
509

P.5.031 Management of dependence of the opioid type

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
511

P.5.033 Predictive factors of drop-out in outpatient treatment for drug dependence

Year:
1997
Language:
english
File:
PDF, 275 KB
english, 1997
516

P.5.038 Alcoholism treatment with antidepressant tianeptine

Year:
1997
Language:
english
File:
PDF, 134 KB
english, 1997
517

P.5.039 Reduced blue cone electroretinogram in cocaine withdrawn patients

Year:
1997
Language:
english
File:
PDF, 134 KB
english, 1997
519

P.5.041 Intracerebral haemorrhage associated with ingestion of “Ecstasy”

Year:
1997
Language:
english
File:
PDF, 134 KB
english, 1997
525

P.6.004 Depression with panic: A 203-case study in private practice

Year:
1997
Language:
english
File:
PDF, 137 KB
english, 1997
534

P.6.013 Co-occurrence of OCD and HD in an Italian pedigree

Year:
1997
Language:
english
File:
PDF, 135 KB
english, 1997
536

P.6.015 Disorders of sex-role identity at paraphilias

Year:
1997
Language:
english
File:
PDF, 147 KB
english, 1997
540

P.6.019 Cognitive state of hypothyroid patients and thyroid hormone replacement

Year:
1997
Language:
english
File:
PDF, 136 KB
english, 1997
550

P.6.029 The prevalence of allergic diseases in affective and anxiety disorders

Year:
1997
Language:
english
File:
PDF, 275 KB
english, 1997
553

P.6.032 Efficacy and safety of fluoxetine treatment of obesity

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
555

P.6.034 The French law on biomedical research

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
557

P.6.036 Temperament as one risk factor of mental disorders

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
561

P.6.040 Psychopharmacotherapy principles of psychoorganic syndrome

Year:
1997
Language:
english
File:
PDF, 136 KB
english, 1997
562

P.6.042 Venlafaxine in mental illness

Year:
1997
Language:
english
File:
PDF, 143 KB
english, 1997
566

P.6.046 Pharmacology of some new DL-aspartic acid derivatives

Year:
1997
Language:
english
File:
PDF, 132 KB
english, 1997
567

P.6.047 Regulatory system of brain chromatin in nootropic action

Year:
1997
Language:
english
File:
PDF, 132 KB
english, 1997
569

P.6.049 Preliminary validation of a checklist of psychiatric disorders

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
571

P.6.051 Are there biochemical markers of vomiting in bulimia nervosa?

Year:
1997
Language:
english
File:
PDF, 139 KB
english, 1997
572

P.6.052 The role of neuropeptides in anthenatalis development

Year:
1997
Language:
english
File:
PDF, 139 KB
english, 1997
575

P.6.055 Immunity in acute manic episode before and during the remission

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
580

P.6.060 The psychiatric population in the emergency room

Year:
1997
Language:
english
File:
PDF, 277 KB
english, 1997
585

P.6.065 Lithium and neuroleptic malignant syndrome

Year:
1997
Language:
english
File:
PDF, 137 KB
english, 1997
589

P.6.069 Psychosocial rehabilitation. The Italian experience

Year:
1997
Language:
english
File:
PDF, 133 KB
english, 1997
592

P.6.072 Inositol treatment of bulemia

Year:
1997
Language:
english
File:
PDF, 149 KB
english, 1997
595

P.6.075 Risperidone in the treatment of neurological disorders

Year:
1997
Language:
english
File:
PDF, 140 KB
english, 1997
604

P.6.085 Suicid attempters in general hospital

Year:
1997
Language:
english
File:
PDF, 138 KB
english, 1997
607

P.6.088 The relation between impulse and obsession

Year:
1997
Language:
english
File:
PDF, 135 KB
english, 1997
609

P.6.090 Nootropic effects of new drug Curdlipid C6

Year:
1997
Language:
english
File:
PDF, 135 KB
english, 1997
611

P.6.092 Dementia in binswanger's encephalopathy

Year:
1997
Language:
english
File:
PDF, 125 KB
english, 1997
612

P.6.093 Citalpram in anorexia nervosa

Year:
1997
Language:
english
File:
PDF, 125 KB
english, 1997
616

P.6.097 On the quality of diagnostics of border neuropsychic disorders in working women

Year:
1997
Language:
english
File:
PDF, 274 KB
english, 1997
617

P.6.098 Ondansetron in the treatment of generalized anxiety disorder

Year:
1997
Language:
english
File:
PDF, 141 KB
english, 1997
622

Author index

Year:
1997
File:
PDF, 99 KB
1997